Diminished Short-Term Efficacy of Reduced-Dose Induction BCG in the Treatment of Non-Muscle Invasive Bladder Cancer

Diminished Short-Term Efficacy of Reduced-Dose Induction BCG in the Treatment of Non-Muscle Invasive Bladder Cancer

The ongoing Bacillus Calmette-Guérin (BCG) shortage has created challenges for the treatment of non-muscle invasive bladder cancer (NMIBCa). Our objective was to evaluate the efficacy of reduced-dose induction BCG (RD-iBCG) compared to full-dose induction BCG (FD-iBCG) regarding recurrence rates. We...

Full description

Bibliographic Details
Main Authors: David A. Ostrowski, Raju R. Chelluri, Matthew Herzig, Leilei Xia, Brian D. Cortese, Daniel S. Roberson, Thomas J. Guzzo, Daniel J. Lee, S. Bruce Malkowicz
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
BCG shortage
reduced dose
bacillus Calmette-Guérin
non-muscle invasive bladder cancer
Online Access:https://www.mdpi.com/2072-6694/15/14/3746

Internet

https://www.mdpi.com/2072-6694/15/14/3746

Similar Items